Newstral
Dendreon
- The Business Case For Expanding Diversity In Clinical TrialsForbes
- LUrothelial Carcinoma Treatment Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: GlaxoSmithKline, Novartis, Merck, Sanofi, Bristol-Myers Squibb, Genentech,…liverpoolstudentmedia.com
- Biotech company Dendreon extends metro Atlanta leasebizjournals.com
- FDA regulations are barring millions from life-saving drug accessocregister.com
- Valeant swings to profit on $1.3-billion tax benefitThe Globe and Mail
- Seattle’s Juno Therapeutics ready for another round in war on cancer - Mon, 25 Sep 2017 PSTThe Spokesman-Review
- MWhat it takes to deliver a cancer therapy during a hurricanemarketwatch.com
- Seattle’s Juno Therapeutics ready for another round in war on cancerseattletimes.com
- Distinctive Corporate Culture: Walk The TalkForbes
- Valeant shares fall as Ackman exit highlights company's challengesReuters
- Drugmaker Valeant selling $1.3B in skincare products to L'OrealUSA today
- Valeant Strikes Deals to Shed Assetswsj.com
- The Motley Fool: Carnival cruises to profits - Sun, 07 Aug 2016 PSTThe Spokesman-Review
- Why I'm Not Worried About Drug Prices (How I Stopped Worrying And Learned To Love The $100,000 Drug)Forbes
- Desperately Seeking Price Reform: The Pharmaceutical Industry Needs To Change Its WaysForbes
- Hackers steal confidential press releases in insider-trading ring that made more than $100 million: authoritiesSydney Morning Herald
- Nine Charged in Insider Trading Scheme Involving HackersVOX recode
- A Cold Wind Blows Through the Corridors of the FDA: Federal Judge Grants Amarin InjunctionForbes
- The Stress Of Urban Blight And Other Public Health Impacts . . . Confirmed Via Geospatial MappingForbes
- Doctors Say This Is The Solution To Terrifying Drug PricesForbes
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.